A systematic review of the effectiveness of adalimumab

136
References
a randomised double blind placebo controlled
trial. Arthritis Rheum 2000;43 (Suppl):S382.
191. Scott DL, Strand V. The effects of diseasemodifying
anti-rheumatic drugs on the Health
Assessment Questionnaire score. Lessons from the
leflunomide clinical trials database. J Rheumatol
2002;41:899–909.
192. Lynch N, Robinson E. Cyclosporin use in
inflammatory arthritis: a 2-year prospective national
audit. Arthritis Rheum 2000;43 (Suppl):S344.
193. Maetzel A, Wong W, Strand V, Tugwell P, Wells G,
Bombardier C. Meta-analysis of treatment
termination rates among rheumatoid arthritis
patients receiving disease modifying antirheumatic
drugs. Rheumatology 2000;39:975–81.
194. Newchurch. National Pathology Alliance
Benchmarking Report: Haematology and blood
transfusion 2000/2001. London: Newchurch; 2002.
195. Newchurch. Radiology Benchmarking Report:
1999/2000. London: Newchurch; 2001.
196. Curtis L, Netten N. Unit costs of health and social care
2004. Canterbury: PSSRU, University of Kent; 2004.
197. British National Formulary. BNF 50; September
2005. URL: www.bnf.org.
198. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch
DA, Williams CA. The mortality of rheumatoid
arthritis. Arthritis Rheum 1994;37:481–94.
199. Sokka T, Hakkinen A, Krishnan E, Hannonen P.
Similar prediction of mortality by the health
assessment questionnaire in patients with
rheumatoid arthritis and the general population.
Ann Rheum Dis 2004;63:494–7.
200. Krishnan E, Sokka T, Häkkinen A, Hubert H,
Hannonen P. Normative values for the Health
Assessment Questionnaire disability index. Arthritis
Rheum 2004;50:953–60.
201. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A.
Measuring health-related quality of life in
rheumatoid arthritis: validity, responsiveness and
reliability of EuroQol (EQ-5D). Br J Rheumatol
1997;36:551–9.
202. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I,
Matteson EL, Montori V. Anti-TNF antibody
therapy in rheumatoid arthritis and the risk of
serious infections and malignancies: systematic
review and meta-analysis of rare harmful effects in
randomized controlled trials. JAMA 2006;
295:2275–85.
203. Jobanputra P, Hunter M, Clark D, Lambert C,
Hurst N. An audit of methotrexate and folic acid
for rheumatoid arthritis. Experience from a
teaching centre. Br J Rheumatol 1995;34:971–5.
204. Fries JF, Spitz PW, Kraines RG, Holman HR.
Measurement of patient outcomes in arthritis.
Arthritis Rheum 1980;23:137–45.
205. Wolfe F. Which HAQ is best? A comparison of the
HAQ, MHAQ and RA-HAQ, a difficult 8 item
HAQ (DHAQ), and a rescored 20 item HAQ
(HAQ20): analyses in 2491 rheumatoid arthritis
patients following leflunomide initiation.
J Rheumatol 2001;28:982–9.
206. Felson DT, Anderson JJ, Boers M, Bombardier C,
Furst D, Goldsmith C, et al. American College of
Rheumatology preliminary definition of
improvement in rheumatoid arthritis. Arthritis
Rheum 1995;38:727–35.
207. Siegel JN, Zhen B-G. Use of the American
College of Rheumatology N (ACR-N) index of
improvement in rheumatoid arthritis. Argument in
favor. Arthritis Rheum 2005;52:1637–41.
208. Boers M. Use of the American College of
Rheumatology N (ACR-N) index of improvement
in rheumatoid arthritis. Argument in opposition.
Arthritis Rheum 2005;52:1642–5.
209. Scott DL. Radiographs in rheumatoid arthritis.
International Journal of Advances in Rheumatology
2003;1:2–8.
210. Sharp JT, Young DY, Bluhm GB, Brook A,
Brower AC, Corbett M, et al. How many joints in
the hands and wrists should be included in a score
of radiologic abnormalities used to assess
rheumatoid arthritis? Arthritis Rheum 1985;
28:1326–35.
211. van der Heijde D, van Leeuwen MA, Riel PLCM,
Koster AM, van ‘T Hof MA, van Rijswijk MH, et al.
Biannual radiographic assessments of hands and
feet in a three-year prospective followup of
patients with early rheumatoid arthritis. Arthritis
Rheum 1992;35:26–34.
212. Scott DL, Housseien DA, Laasonen L. Proposed
modification to Larsen’s scoring methods of hand
and wrist radiographs. Br J Rheumatol 1995;
34:56.
213. Fleischmann RM, Baumgartner SW, Tindall EA,
Weaver AL, Moreland LW, Schiff MH, et al.
Response to etanercept (Enbrel) in elderly patients
with rheumatoid arthritis: a retrospective analysis
of clinical trial results. J Rheumatol 2003;30:691–6.
214. Smeets TJ, Kraan MC, van Loon ME, Tak PP.
Tumor necrosis factor alpha blockade reduces the
synovial cell infiltrate early after initiation of
treatment, but apparently not by induction of
apoptosis in synovial tissue. Arthritis Rheum 2003;
48:2155–62.
215. St Clair EW, Wagner CL, Fasanmade AA, Wang B,
Schaible T, Kavanaugh A, et al. The relationship of
serum infliximab concentrations to clinical
improvement in rheumatoid arthritis: results from
ATTRACT, a multicenter, randomized, doubleblind,
placebo-controlled trial. Arthritis Rheum
2002;46:1451–9.